Article section
Impact of Cortisol and Sex Hormone Imbalance on Obesity and Insulin Resistance Among Iraqis: A Case-Control Study
Abstract
Obesity is a multifaceted metabolic condition affected by hormonal and environmental elements. There is growing awareness of how dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis and changes in sex hormone levels play a role in insulin resistance linked to obesity. Increased cortisol levels, along with fluctuations in testosterone and estradiol, can interfere with glucose metabolism and fat distribution, leading to various metabolic issues. This research focused on examining the relationship between circulating cortisol and the levels of sex hormones (testosterone and estradiol) in relation to obesity and insulin resistance in adults. A case-control study was carried out with obese and non-obese participants who were matched by age and sex. Key measurements included anthropometric data (such as BMI and waist circumference) and fasting biochemical markers. Serum levels of cortisol, testosterone, and estradiol were analyzed using enzyme-linked immunosorbent assay (ELISA). Insulin resistance was evaluated through the Homeostasis Model Assessment for Insulin Resistance (HOMA-IR). Statistical analyses employed correlation and regression tests to investigate the relationships between hormone levels and metabolic indicators. Obese individuals exhibited notably higher levels of serum cortisol and lower levels of testosterone compared to non-obese controls (p < 0.001). Additionally, estradiol levels were significantly increased in obese females. After controlling for BMI, cortisol and testosterone were found to be independently linked to HOMA-IR, suggesting their role in insulin resistance. An imbalance in cortisol and sex hormones is closely linked to obesity and insulin resistance. These changes in hormone levels might act as early warning signs of metabolic risk and could potentially be targeted for therapeutic approaches in addressing obesity-related conditions.
Keywords:
Article information
Journal
Journal of Medical Science, Biology, and Chemistry
Volume (Issue)
2(2), (2025)
Pages
262-266
Published
Copyright
Copyright (c) 2025 Ali B. Abdulrazzaq (Author)
Open access

This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
Abraham, S., Rubino, D., Sinaii, N., Ramsey, S., & Nieman, L. K. (2013). Cortisol, obesity, and the metabolic syndrome: A cross‐sectional study of obese subjects and review of the literature. Obesity, 21(1), E105–E117.
Anagnostis, P., Athyros, V. G., Tziomalos, K., Karagiannis, A., & Mikhailidis, D. P. (2009). The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. The Journal of Clinical Endocrinology & Metabolism, 94(8), 2692–2701.
Bae, Y. J., & Kratzsch, J. (2015). Corticosteroid-binding globulin: modulating mechanisms of bioavailability of cortisol and its clinical implications. Best Practice & Research Clinical Endocrinology & Metabolism, 29(5), 761–772.
Bastien, M., Poirier, P., Lemieux, I., & Després, J.-P. (2014). Overview of epidemiology and contribution of obesity to cardiovascular disease. Progress in Cardiovascular Diseases, 56(4), 369–381.
Beaupere, C., Liboz, A., Fève, B., Blondeau, B., & Guillemain, G. (2021). Molecular mechanisms of glucocorticoid-induced insulin resistance. International Journal of Molecular Sciences, 22(2), 623.
Bianchi, V. E., & Locatelli, V. (2018). Testosterone a key factor in gender related metabolic syndrome. Obesity Reviews, 19(4), 557–575.
Ciardullo, S., Zerbini, F., Cannistraci, R., Muraca, E., Perra, S., Oltolini, A., & Perseghin, G. (2023). Differential association of sex hormones with metabolic parameters and body composition in men and women from the United States. Journal of Clinical Medicine, 12(14), 4783.
Friedman, M. I., Sørensen, T. I. A., Taubes, G., Lund, J., & Ludwig, D. S. (2024). Trapped fat: Obesity pathogenesis as an intrinsic disorder in metabolic fuel partitioning. Obesity Reviews, 25(10), e13795.
Janssen, J. A. (2022). New insights into the role of insulin and hypothalamic-pituitary-adrenal (HPA) axis in the metabolic syndrome. International Journal of Molecular Sciences, 23(15), 8178.
Kelly, D. M., & Jones, T. H. (2015). Testosterone and obesity. Obesity Reviews, 16(7), 581–606.
Mauvais-Jarvis, F. (2011). Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity. Trends in Endocrinology & Metabolism, 22(1), 24–33.
Mazgelytė, E., & Karčiauskaitė, D. (2024). Cortisol in metabolic syndrome. Advances in Clinical Chemistry, 123, 129–156.
Mazza, E., Troiano, E., Ferro, Y., Lisso, F., Tosi, M., Turco, E., … Montalcini, T. (2024). Obesity, dietary patterns, and hormonal balance modulation: gender-specific impacts. Nutrients, 16(11), 1629.
Min, L. (2016). Functional hypercortisolism, visceral obesity and metabolic syndrome. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 22(4), 506.
Min, S. H., Kim, S.-H., Jeong, I.-K., Cho, H. C., Jeong, J.-O., Lee, J.-H., … Lim, S. (2018). Independent association of serum aldosterone level with metabolic syndrome and insulin resistance in Korean adults. Korean Circulation Journal, 48(3), 198-208.
Paredes, S., & Ribeiro, L. (2014). Cortisol: the villain in metabolic syndrome? Revista Da Associação Médica Brasileira, 60, 84–92.
Rezaieg, N. S. (2021). Negative associations of diurnal cortisol levels with visceral obesity in adults male and female. Turkish Journal of Physiotherapy and Rehabilitation, 32(3).
Salehidoost, R., & Korbonits, M. (2022). Glucose and lipid metabolism abnormalities in C ushing’s syndrome. Journal of Neuroendocrinology, 34(8), e13143.
Sheikh, A. B., Nasrullah, A., Haq, S., Akhtar, A., Ghazanfar, H., Nasir, A., … Naqvi, S. W. (2017). The interplay of genetics and environmental factors in the development of obesity. Cureus, 9(7).
Signorello, M. G., Ravera, S., & Leoncini, G. (2024). Oxidative stress induced by cortisol in human platelets. International Journal of Molecular Sciences, 25(7), 3776.
Van Hulsteijn, L. T., Pasquali, R., Casanueva, F., Haluzik, M., Ledoux, S., Monteiro, M. P., … Dekkers, O. M. (2020). Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis. European Journal of Endocrinology, 182(1), 11–21.
Wang, F., Vihma, V., Soronen, J., Turpeinen, U., Hämäläinen, E., Savolainen-Peltonen, H., … Jauhiainen, M. (2013). 17β-Estradiol and estradiol fatty acyl esters and estrogen-converting enzyme expression in adipose tissue in obese men and women. The Journal of Clinical Endocrinology & Metabolism, 98(12), 4923–4931.
Wawrzkiewicz-Jałowiecka, A., Lalik, A., & Soveral, G. (2021). Recent update on the molecular mechanisms of gonadal steroids action in adipose tissue. International Journal of Molecular Sciences, 22(10), 5226.
Yan, H., Yang, W., Zhou, F., Li, X., Pan, Q., Shen, Z., … Majeti, R. (2019). Estrogen improves insulin sensitivity and suppresses gluconeogenesis via the transcription factor Foxo1. Diabetes, 68(2), 291–304.
Yan, Y.-X., Xiao, H.-B., Wang, S.-S., Zhao, J., He, Y., Wang, W., & Dong, J. (2016). Investigation of the relationship between chronic stress and insulin resistance in a Chinese population. Journal of Epidemiology, 26(7), 355–360.
Stecab Publishing

Call for Papers
Author's Guidelines
Manuscript Template
References Guideline
Join in Editorial Team